{
  "docId": "019dd923-5fec-763b-95ce-df36eb136cb7",
  "docSlug": "v2M0U9ih51yxmXlSsD1M",
  "documentTitle": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad",
  "authorId": "Pitchdecks",
  "authorName": "Beckley Psytech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 18,
  "pageCount": 22,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a tiered layout to represent a progression of innovation or maturity.",
  "elementsJson": [
    "action_title",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/18",
  "deckHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.58
      },
      "kind": "list",
      "text": "3rd Generation (NCEs): Composition of matter IP. Potential clinical and safety advantages over existing psychedelic compounds.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a3f84b1-5c00-4680-ad58-65d1509ba5f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.26
      },
      "kind": "list",
      "text": "1st Generation (Confidential): Differentiated application, market segment, and treatment model. Additional data and market exclusivity protections.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83e2c3d6-b853-42f6-a31c-ebcfac70f733",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.41
      },
      "kind": "list",
      "text": "2nd Generation (5-MeO-DMT): Early Mover in 5-MeO-DMT. Strong potential for innovation, IP, and market exclusivity protection. Significant market access and resource efficiencies over longer-acting psychedelics.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c7c13a0-9618-4cc1-be4e-04eaec886cd2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.73
      },
      "kind": "list",
      "text": "Beckley Deep Labs: Horizon scanning to guide advanced research and differentiated development programs. Accelerated expansion of the Beckley Psytech platform with pioneering partnerships.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b2508f6e-c83e-4ba0-841e-3a2af99a961a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Competitive Positioning: Each program offers clear market differentiation with clinical and commercial advantages",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "403d856d-7a3c-4dbe-b125-4b5d41fb1d93",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Market Segmentation Pyramid",
      "slug": "market-segmentation-pyramid",
      "agent": null,
      "layer": "slide",
      "matchId": "0ed014b1-4ec1-429d-89a4-675f88fc79d4",
      "evidence": "2nd Generation (5-MeO-DMT): Early Mover in 5-MeO-DMT. Strong potential for innovation, IP, and market exclusivity protection",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "maturity-model",
      "slug": null,
      "matchId": "c409dda2-d11f-4131-9f5a-1357de387174",
      "evidence": "The slide organizes programs into generations (1st, 2nd, 3rd) representing a progression of development.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}